German Rheumatism Research Centre

Recent papers from German Rheumatism Research Centre

1. Identification of Plasmodium sporozoites using angle-resolved scattered light pulse shapesPLoS ONE · 2026
2. Safeguarding functionality of ATMPs: in-depth characterization of cryopreserved GMP-compliant nTreg products for therapeutic useFrontiers in Cell and Developmental Biology · 2026
3. Local albumin excess exacerbates Candida albicans-induced inflammasome activation linked with hyperinflammation during vulvovaginal candidiasisNature Communications · 2026
4. Predictors of b/tsDMARDs discontinuation and treatment response in psoriatic arthritis: results from the British Society for Rheumatology Psoriatic Arthritis Register (BSR-PsA)Lara D. Veeken · 2026
5. Plasma cells – a key target in antibody-mediated diseasesCellular and Molecular Life Sciences · 2026
6. C5 Inhibition for Anti-Cancer Therapy-Induced Renal Thrombotic MicroangiopathyNephrology Dialysis Transplantation · 2026
7. Ianalumab for the Treatment of Patients with Sjögren’s DiseaseNew England Journal of Medicine · 2026
8. Depressive symptoms are associated with achieving remission in PsA patients – an analysis from the RABBIT-SpA registerBMC Rheumatology · 2026
9. CAR T-cell activity for autoimmune diseases across EBMT centers: an international survey on behalf of the Autoimmune Diseases Working Party and the Cellular Therapy and Immunobiology Working PartyHaematologica · 2026
10. OsteoCHAT: real-world patient evaluation and benchmarking of a guideline-grounded osteoporosis chatbotOsteoporosis International · 2026
11. Immune reset in rheumatic autoimmune disease: from a tantalising metaphor to a measurable therapeutic stateAnnals of the Rheumatic Diseases · 2026
12. Study on the implementation of the 2015 EULAR/ACR recommendations for polymyalgia rheumatica in clinical practiceRMD Open · 2026
13. Immune profiling of anti-SSA–positive at-risk individuals reveals increased type I IFN activity preceding lymphocyte abnormalities in Sjögren’s diseaseFrontiers in Immunology · 2026
14. Outcomes in JIA have greatly improved, but we can still do betterArthritis Research & Therapy · 2026
15. Predicting prevalence and severity of cytokine release syndrome after CAR T-cell therapy in patients with autoimmune disease: a retrospective cohort studyThe Lancet Rheumatology · 2026
16. Aire is a cell-intrinsic regulator of natural IgM-secreting cellsImmunity · 2026
17. Community Health Research in the new German Center for Child and Adolescent Health (DZKJ).2026
18. Agranulocytosis associated with metamizole among EudraVigilance reports involving methotrexate for rheumatoid arthritisNaunyn-Schmiedeberg s Archives of Pharmacology · 2026
19. Elucidating the Impact of Bacterial Composition and Diversity on Skin Homeostasis Using a Human 3D In Vitro Skin ModelMicroorganisms · 2026
20. Exploratory Analysis of the Inhibitory Effects of Propranolol on NLRP3 and Pyrin InflammasomesACR Open Rheumatology · 2026